نتائج البحث - "Gallium-68"

1

Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review

المؤلفون: Aymen Al Hadidi, Badriya Al Suqri, Naima Al Bulushi, Marwa Al Aamri, Mimouna Al Risi, Mohammed Al Zadjali, Hafidh Al Jahdami

المصدر: World Journal of Nuclear Medicine, Vol 18, Iss 2, Pp 137-142 (2019)
World Journal of Nuclear Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4a2e30ca9ef89fba2c42c2c1598696Test
http://www.wjnm.org/article.asp?issn=1450-1147;year=2019;volume=18;issue=2;spage=137;epage=142;aulast=AlTest

2

Does the proteasome inhibitor bortezomib sensitize to DNA- damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo

المؤلفون: Anja A. Kühl, Monique R. Bernsen, Winfried Brenner, M. Welzel, Richard P. Baum, Samantha Exner, Eva J. Koziolek, Jakob Albrecht, Dagmar Sedding, Patricia Grabowski, Christian Fischer, Fränze Schmidt, Teresa Hartung, Joost C. Haeck, Franziska Briest, Carsten Grötzinger

المساهمون: Radiology & Nuclear Medicine

المصدر: Neoplasia (New York, N.Y.)
BASE-Bielefeld Academic Search Engine
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 1, Pp 80-98 (2021)
Neoplasia (United States), 23(1), 80-98

مصطلحات موضوعية: Apoptosis, FOXO3a, forkheadbox protein O3a, d, day(s), Rb, retinoblastoma protein, Mice, 0302 clinical medicine, JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide, Molecular Targeted Therapy, BER, base excision repair, Bortezomib, IC50, dose of half-maximum inhibitory effect, Ga-68, Gallium-68, Drug Synergism, DSMZ, Deutsche Sammlung für Mikroorganismen und Zellen, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunohistochemistry, Neuroendocrine Tumors, G0/1/2 phase, gap phase 0/1/2, 030220 oncology & carcinogenesis, CAM, chorioallantoic membrane, (M)Bq, (Mega-)Becquerel, Original article, PRRT, peptide receptor radionuclide therapy, DNA damage, p70S6K, ribosomal protein S6 kinase, DNA repair, Antineoplastic Agents, NEN, neuroendocrine neoplasms, ERK, extracellular-signal-regulated kinase, lcsh:RC254-282, AP-sides, apurinic or apyrimidinic sites, M phase, mitosis phase, 03 medical and health sciences, SDG 3 - Good Health and Well-being, In vivo, i.v., intravenous, NER, nucleotide excision repair, GO, Gene Ontology, Humans, Combination therapy, FOXM1, forkheadbox protein M1, Cisplatin, G1/2/3, grade 1/2/3, Dose-Response Relationship, Drug, Proteasome inhibition, Cell Cycle Checkpoints, n, number, H2AX, histone H2AX, 030104 developmental biology, Proteasome, NHEJ, non-homologous end joining, g, gram, Proteasome inhibitor, HR, homologous recombination, 0301 basic medicine, Cancer Research, BRIP1, BRCA1 Interacting Protein C-Terminal Helicase 1, Chick Embryo, RPA, replication protein A, GEP-NEN, gastroenteropancreatic neuroendocrine neoplasms, SCLC, small cell lung cancer, Gene Regulatory Networks, TGF, transforming growth factor, HTCA, human tumor colony assay, Gastrointestinal Neoplasms, i.p., intraperitoneal, M, molar, Lu-177, Lutetium-177, Proteasome Inhibitors, F-18-FDG-PET, 2-deoxy-2-(F-18)fluoro-D-glucose positron emission tomography, SSTR2, somatostatin receptor 2, PI3K, phosphoinositide 3-kinase, medicine.drug, DDR, DNA damage repair, MMR, mismatch repair, SKP2, S-Phase Kinase Associated Protein 2, PARP1, poly(ADP-ribose) polymerase 1, (RT)-PCR, (real-time) polymerase chain reaction, BRCA1/2, breast cancer protein 1/2, ER, endoplasmic reticulum, ROS, reactive oxygen species, S phase, synthesis phase, Cell Line, Tumor, h, hour(s), medicine, Animals, TLS, translesion synthesis, Cell Proliferation, business.industry, DSB, double-strand breaks, PTEN, phosphatase and tensin homolog, CK2, casein kinase 2, Drug Resistance, Neoplasm, Radionuclide therapy, SSB, single-strand breaks, Cancer research, business, MRI, magnetic resonance imaging, DNA Damage, Peptide receptor radionuclide therapy (PRRT)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b0fcaaba5da9ca61e63d327232b0b4Test
http://www.scopus.com/inward/record.url?scp=85096683387&partnerID=8YFLogxKTest

3

DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine

المؤلفون: Elisabeth Eppard, Markus Essler, Stefan Kürpig, Michael Meisenheimer

المصدر: Molecules
Volume 25
Issue 13
Molecules, Vol 25, Iss 2988, p 2988 (2020)

مصطلحات موضوعية: Quality Control, medicine.medical_specialty, Pharmaceutical Science, Bone Neoplasms, Gallium Radioisotopes, Zoledronic Acid, Article, Analytical Chemistry, lcsh:QD241-441, 03 medical and health sciences, chemistry.chemical_compound, Heterocyclic Compounds, 1-Ring, 0302 clinical medicine, lcsh:Organic chemistry, gallium-68, Drug Discovery, medicine, DOTA, Humans, Medical physics, Physical and Theoretical Chemistry, Purification methods, 030304 developmental biology, bone metastasis, 0303 health sciences, Bone Density Conservation Agents, business.industry, Organic Chemistry, Bronchial Neoplasms, Palliative Care, Bone metastasis, medicine.disease, Clinical routine, Palliative Therapy, radiolabelling synthesis, Zoledronic acid, chemistry, Chemistry (miscellaneous), module system, 030220 oncology & carcinogenesis, Isotope Labeling, Molecular Medicine, Radiopharmaceuticals, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a882ff81b98656821c68271e98259f9dTest
http://europepmc.org/articles/PMC7412164Test

4

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

المؤلفون: A. Rauscher, Jacques Barbet, Caroline Bodet-Milin, Evelyne Cerato, Mickaël Bourgeois, A. David, Céline Bossard, Yann Touchefeu, Clément Bailly, Françoise Kraeber-Bodéré, T. Eugène, Damien Masson, Eric Frampas, David M. Goldenberg, Thomas Carlier, Alain Faivre-Chauvet, Robert M. Sharkey, Caroline Rousseau

المساهمون: Nuclear Oncology (CRCINA-ÉQUIPE 13), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Service de Radiologie [Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Département de Pathologie [CHU Nantes], Unité de Pharmacie [ICO, Saint Herblain], Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER-UNICANCER, Délégation à la Recherche Clinique et à l'Enovation [Nantes] ((DRCI)), Hôtel-Dieu-Centre hospitalier universitaire de Nantes (CHU Nantes), Immunomedics Inc. [Morris Plains, NJ, USA], IBC Pharmaceuticals Inc [Morris Plains, NJ, USA], ARRONAX - (GIP) Groupement d'Intérêt Public [Saint-Herblain] (Institut de Recherche Public), Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, 48, pp.874-882. ⟨10.1007/s00259-020-04989-3⟩
European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48, pp.874-882. ⟨10.1007/s00259-020-04989-3⟩

مصطلحات موضوعية: Endoscopic ultrasound, Bispecific antibody, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gallium Radioisotopes, Pilot Projects, Colorectal cancer metastases, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Heterocyclic Compounds, 1-Ring, 0302 clinical medicine, Carcinoembryonic antigen, [SDV.CAN] Life Sciences [q-bio]/Cancer, Fluorodeoxyglucose F18, Biopsy, medicine, Humans, Radiology, Nuclear Medicine and imaging, Immuno-positron emission tomography, Fluorodeoxyglucose, medicine.diagnostic_test, biology, Bispecific monoclonal antibody, business.industry, Gallium-68, Antibodies, Monoclonal, Magnetic resonance imaging, General Medicine, 3. Good health, Carcinoembryonic Antigen, Positron emission tomography, 030220 oncology & carcinogenesis, Positron-Emission Tomography, biology.protein, Nuclear medicine, business, Colorectal Neoplasms, Pretargeted radioimmunoimaging, Oligopeptides, Emission computed tomography, medicine.drug